Achieve Life Sciences Enters ATM Sale Agreement With Jefferies For Up To $150M In Common Stock
-SEC Filing
Stocks · News reference
Morgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13
Morgan Stanley analyst Maxwell Skor initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Overweight rating and announces Price Target of $13.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
This Vail Resorts Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
Wall Street analysts changed outlook on top names. Check analyst ratings page for all changes. See what analysts think of MTN stock.
Achieve Life Sciences Q2 EPS $(0.80) Misses $(0.16) Estimate
Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.16) by 400 percent. This is a 116.22 percent decrease over losses of $(0.37) per